CORESTATE Capital Holding S.A (CCAP)
XETRA Stock Exchange · Germany · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 0.180 |
|---|---|
| 52-week range | 0.166 – 0.320 |
| Return, 1 month / 3 months | −26.5% / −27.4% |
| Return, 1 year / 3 years | −37.9% / −66.7% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 51.9% |
| Worst drawdown (1 year) | -42.9% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Corestate Capital Holding is a real estate investment manager based in Luxembourg. The company manages property assets and provides investment management services, mainly to institutional investors and other professional clients. Its activities cover real estate equity and debt investments, with a focus on residential and commercial property in Germany and other European markets. Corestate works with partners to structure and manage property investment vehicles on behalf of its clients.
CORESTATE Capital Holding S.A trades under the code CCAP on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CORESTATE Capital Holding S.A (CCAP) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 0.180 on 19 October 2026.
Its price-based Market X-Ray is 18 out of 100 (a weak price profile), ranking 636 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 37.9% and over the last three months it fell 27.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 18 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.4% | ||
| From 52-week high | -42.9% | ||
| Momentum | 18 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -27.4% | ||
| 6-month return | -25.0% | ||
| 12-month return, skipping the last month | -15.5% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.9% | ||
| Liquidity | 6 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | −26.5% |
| 3 months | −27.4% |
| 6 months | −25.0% |
| 1 year | −37.9% |
| 3 years | −66.7% |
| 5 years | −98.3% |
Signals
| 50-day / 200-day average | 0.220 / 0.238 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.025 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Apr 2019 | EUR 2.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.